Cargando…
Evidence for altered opioid activity in patients with cancer.
Endogenous opioid peptides have been shown to be involved in the regulation of tumour growth. At present, however, no data are available about the secretion of opioid peptides in cancer patients. To draw some preliminary conclusions on opioid brain function in human neoplasms, we evaluated hypophyse...
Autores principales: | Lissoni, P., Barni, S., Paolorossi, F., Crispino, S., Rovelli, F., Ferri, L., Delitala, G., Tancini, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002387/ https://www.ncbi.nlm.nih.gov/pubmed/2963662 |
Ejemplares similares
-
A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients.
por: Lissoni, P., et al.
Publicado: (1996) -
Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients.
por: Lissoni, P., et al.
Publicado: (1990) -
Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.
por: Lissoni, P., et al.
Publicado: (1989) -
Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2.
por: Lissoni, P., et al.
Publicado: (1991) -
A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.
por: Lissoni, P., et al.
Publicado: (1994)